thisdrug what a medicine's name tells you

WHO naming stem · suffix · 32 listed names

-dotin

This page was written with AI.

synthetic derivatives of dolastatin series

WHO's definition, quoted as written in the 2024 stem book

6 of 32 names appear in these lists: 6 in the US list (FDA Drugs@FDA) and 5 in the EU central list (EMA); 5 have national brands in at least one EU/EEA country.

Names only. This page is about -dotin as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -dotin. So the letters dotin sit at the end of the name (…dotin).

All 32 names WHO lists under -dotin

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 6 of 32 names appear in these lists: 6 in the US list (FDA Drugs@FDA) and 5 in the EU central list (EMA); 5 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. anvatabart opadotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. aprutumab ixadotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  3. azintuxizumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. belantamab mafodotin
    US brands: BLENREP
    EU (central) brands: Blenrep
  5. brentuximab vedotin
    US brands: ADCETRIS
    EU (central) brands: Adcetris
  6. cemadotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  7. cofetuzumab pelidotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. denintuzumab mafodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  9. depatuxizumab mafodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  10. enapotamab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. enfortumab vedotin
    US brands: PADCEV
    EU (central) brands: Padcev
  12. glembatumumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  13. iladatuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  14. indusatumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  15. ladiratuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  16. lifastuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  17. lonigutamab ugodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  18. losatuxizumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  19. pinatuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. polatuzumab vedotin
    US brands: POLIVY
    EU (central) brands: Polivy
  21. samrotamab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  22. sirtratumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  23. soblidotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  24. sofituzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  25. tasidotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  26. telisotuzumab vedotin
    US brands: EMRELIS
    EU (central) brands: none found
  27. tisotumab vedotin
    US brands: TIVDAK
    EU (central) brands: Tivdak
  28. trastuzumab botidotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  29. upinetatug rilsodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  30. vandortuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  31. vorsetuzumab mafodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  32. zanidatamab zovodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Decode another name

Decoded

cemadotin

Listed INNCarries the WHO stem -dotin

  • -dotinend of the nameWHO lists it hereWHO definition: synthetic derivatives of dolastatin series

“cemadotin” is an INN that WHO lists under -dotin in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -dotin (Part II B) and the 32 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy